Dong Geng

Dr. Dong Geng joined Legend Biotech in 2018. Since then, Dr. Geng has taken increasing responsibilities primarily in Legend’s R&D portfolio development. She is responsible for non-clinical safety, pre-clinical and clinical pharmacology and translational sciences. Dr. Geng brought more than 22 years of biopharma industry experience to Legend. Prior to joining Legend, Dr. Geng had worked in leading biotech and pharmaceutical companies including Johnson and Johnson, BMS, Regeneron, Eli Lilly, and Merck. She has extensive experience in translational development of biologics especially immune-oncology therapies. During her career she has contributed and led numerous IND submissions and at least 7 successful BLA filings.

Dong received her Ph.D. in Biochemistry from Boston College.